Brust Bernd
Chief Executive Officer
Brust Bernd has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Brust Bernd is listed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC. Inside the rolling window, Brust Bernd reported 3 open-market purchases totaling $1.5M in MRVI and no open-market sales. The largest disclosed transaction in the window is a purchase of 216,212 MRVI shares on Nov 13, 2025, worth $703K.
Companies traded
Other insiders at MRVI
Insider Buying
$1.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brust Bernd made?
Brust Bernd has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Brust Bernd trade?
Brust Bernd has filed SEC Form 4 disclosures for 1 company, including MRVI.
When was Brust Bernd's most recent SEC Form 4 filing?
Brust Bernd's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Brust Bernd's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brust Bernd is listed as Chief Executive Officer.
What is Brust Bernd's total buy and sell value in the current window?
Inside the rolling retention window, Brust Bernd bought $1.5M and sold $0 based on SEC Form 4 filings.
What was Brust Bernd's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 216,212 MRVI shares on 2025-11-13, worth $703K, per SEC Form 4 filings.